D-0293-2015 Class II Terminated
FDA drug recall D-0293-2015 was initiated by Baxter Healthcare Corp. on Apr 24, 2014 and is designated Class II. Reason for recall: Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed… The recall status is terminated (terminated Jun 16, 2015). Affected quantity: 19,152 Containers.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 17, 2014
- Initiation Date
- Apr 24, 2014
- Termination Date
- Jun 16, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,152 Containers
Product Description
Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.
Reason for Recall
Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.
Distribution Pattern
Nationwide
Code Information
Lot #: NC082768, Exp 12/23/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0293-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026